Alfred Tager
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alfred Tager has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Frank Annie
CAMC Institute for Academic Medicine, Charleston Area Medical Center, Charleston, WV, United States of America
8 shared publications - Abhishek Bhagat
Internal Medicine, Charleston Area Medical Center, Charleston, USA
4 shared publications - Sarah Embrey
Pharmacy, University of Charleston School of Pharmacy, Charleston, USA
3 shared publications - Vallabh Karpe
Internal Medicine, Charleston Area Medical Center, Charleston, USA
3 shared publications - Ali Farooq
Cardiology, Charleston Area Medical Center, Charleston, USA
2 shared publications - Aravinda Nanjundappa
Cardiology, Charleston Area Medical Center, Charleston, USA
2 shared publications
Latest Publications
- 13 April 2023
- Published by Elsevier in Air Medical Journal
- Vol. 42 (4) , 252-258
Prehospital Active and Passive Warming in Trauma Patients
- 13 April 2023
- Published by Elsevier in Air Medical Journal
- Vol. 42 (4) , 252-258
Prehospital Active and Passive Warming in Trauma Patients
- Open Access
The Relevance of Lactate Levels in Acute Seizure
Introduction Seizures can result in profound elevations of serum lactate. A paucity of investigation into whether lactate levels in these patients is associated with increased mortality. We sought to evaluate the significance in patients presenting with a seizure and elevated lactate. Methods This is a retrospective study involving patients presenting to the Emergency Department (ED) with a diagnosis of seizure from September 1st, 2016 until March 31st, 2018. Those with normal serum lactate (< 2mmol/L) were compared with patients that had an elevated serum lactate (≥ 2mmol/L). Results Patients with normal serum lactate levels had a significantly longer length of stay in the ED (60 minutes p = 0.04) when compared to those with elevated serum lactate levels. Additionally, a higher percentage of patients with elevated serum lactate received intravenous fluids in the ED (54.69% vs. 35.4%, P=0.01). There was no significant difference in other measured variables. Conclusion This study illustrates that serum lactate levels do not directly correlate with indicators of disease severity or outcomes when elevated secondary to seizure. However, patients with normal serum lactate levels had a longer length of stay in the ED.
Open AccessThe Relevance of Lactate Levels in Acute Seizure
Introduction Seizures can result in profound elevations of serum lactate. A paucity of investigation into whether lactate levels in these patients is associated with increased mortality. We sought to evaluate the significance in patients presenting with a seizure and elevated lactate. Methods This is a retrospective study involving patients presenting to the Emergency Department (ED) with a diagnosis of seizure from September 1st, 2016 until March 31st, 2018. Those with normal serum lactate (< 2mmol/L) were compared with patients that had an elevated serum lactate (≥ 2mmol/L). Results Patients with normal serum lactate levels had a significantly longer length of stay in the ED (60 minutes p = 0.04) when compared to those with elevated serum lactate levels. Additionally, a higher percentage of patients with elevated serum lactate received intravenous fluids in the ED (54.69% vs. 35.4%, P=0.01). There was no significant difference in other measured variables. Conclusion This study illustrates that serum lactate levels do not directly correlate with indicators of disease severity or outcomes when elevated secondary to seizure. However, patients with normal serum lactate levels had a longer length of stay in the ED.
- Open Access
- 23 February 2021
- Published by Springer Nature in Cureus
- Vol. 13 (2)
An Evaluation of the Use of Aggressive Fluid Resuscitation in the Early Treatment of Sepsis Patients
Fluid resuscitation is a critical aspect of the sepsis protocol with the usual initial dose being 30 mL per kilogram. Although this dose is well accepted in patients with normal cardiac function, there is some significant variation in clinical practice concerning the optimal fluid resuscitation in septic patients with underlying congestive heart failure (CHF). Many different approaches have been tried to best treat these patients by using lesser volumes of fluid. The purpose of this retrospective study is to attempt to better define optimal fluid resuscitation in congestive heart failure patients and whether standard fluid resuscitation exacerbates CHF in these cases. This was a retrospective study involving patients admitted to the Emergency Department (ED) during the time period of September of 2016 through March of 2019 with a primary diagnosis of sepsis and pre-existing CHF. Data collected from the data warehouse and patient charts included demographics, total amount of fluid received in the ED and outcome data. Evidence of fluid overload (chest X-ray [CXR] evidence, rising B-type natriuretic peptide [BNP], or use of diuretics), was evaluated with respect to in-hospital mortality, white blood cell (WBC) count and comorbidities (chronic obstructive pulmonary disease [COPD], hypertension and coronary artery disease). There were 422 patients included in the cohort. Of the 422, 113 (26.8%) patients showed evidence of fluid overload on CXR during hospital stay and received diuretics and therefore considered in the CHF exacerbation group. The patients that experienced CHF exacerbation were significantly older (mean ± SD, 70.9 ± 11.8 years versus 67.4 ± 15.1 years, p=0.014). Patients with exacerbation also received more fluid (median and interquartile range, 3.0, 2:5.5 L versus 2.0, 1:4.3 L, p=0.017). The receiver operating characteristic curve analysis for fluid to predict exacerbation resulted in an area under the curve of 0.59 with a 95% confidence interval (CI) of 0.52 to 0.65, p=0.012. The Youden Index was used to determine an optimal cutoff value of 2.6 L. The percentage of patients in the exacerbation group above the threshold was significantly higher (57.3%) than those without exacerbation (43.3%), p=0.019. Following multivariate analysis, age greater than 60 (odds ratio [OR]: 2.5; CI: 1.4-4.6, p=0.003) and fluid cutoff of 2.6 L (OR: 1.9; CI: 1.2-3.1, p=0.007) were both found to be independent predictors of CHF exacerbation. There was no significant difference in mortality based on the total fluid received in the ED. The findings of this study showed that septic patients with pre-existing CHF who received more than 2.6 L of fluid in the ED were 90% more likely to develop symptoms of CHF exacerbation with no evidence of lowering mortality compared to the group that received less than 2.6 L. Our data supports the practice of limiting total fluid resuscitation in CHF to 2.6 L and reconfirms the idea that fluid resuscitation for patients with CHF needs to be individualized.
- 23 February 2021
- Published by Springer Nature in Cureus
- Vol. 13 (2)
Open AccessAn Evaluation of the Use of Aggressive Fluid Resuscitation in the Early Treatment of Sepsis Patients
Fluid resuscitation is a critical aspect of the sepsis protocol with the usual initial dose being 30 mL per kilogram. Although this dose is well accepted in patients with normal cardiac function, there is some significant variation in clinical practice concerning the optimal fluid resuscitation in septic patients with underlying congestive heart failure (CHF). Many different approaches have been tried to best treat these patients by using lesser volumes of fluid. The purpose of this retrospective study is to attempt to better define optimal fluid resuscitation in congestive heart failure patients and whether standard fluid resuscitation exacerbates CHF in these cases. This was a retrospective study involving patients admitted to the Emergency Department (ED) during the time period of September of 2016 through March of 2019 with a primary diagnosis of sepsis and pre-existing CHF. Data collected from the data warehouse and patient charts included demographics, total amount of fluid received in the ED and outcome data. Evidence of fluid overload (chest X-ray [CXR] evidence, rising B-type natriuretic peptide [BNP], or use of diuretics), was evaluated with respect to in-hospital mortality, white blood cell (WBC) count and comorbidities (chronic obstructive pulmonary disease [COPD], hypertension and coronary artery disease). There were 422 patients included in the cohort. Of the 422, 113 (26.8%) patients showed evidence of fluid overload on CXR during hospital stay and received diuretics and therefore considered in the CHF exacerbation group. The patients that experienced CHF exacerbation were significantly older (mean ± SD, 70.9 ± 11.8 years versus 67.4 ± 15.1 years, p=0.014). Patients with exacerbation also received more fluid (median and interquartile range, 3.0, 2:5.5 L versus 2.0, 1:4.3 L, p=0.017). The receiver operating characteristic curve analysis for fluid to predict exacerbation resulted in an area under the curve of 0.59 with a 95% confidence interval (CI) of 0.52 to 0.65, p=0.012. The Youden Index was used to determine an optimal cutoff value of 2.6 L. The percentage of patients in the exacerbation group above the threshold was significantly higher (57.3%) than those without exacerbation (43.3%), p=0.019. Following multivariate analysis, age greater than 60 (odds ratio [OR]: 2.5; CI: 1.4-4.6, p=0.003) and fluid cutoff of 2.6 L (OR: 1.9; CI: 1.2-3.1, p=0.007) were both found to be independent predictors of CHF exacerbation. There was no significant difference in mortality based on the total fluid received in the ED. The findings of this study showed that septic patients with pre-existing CHF who received more than 2.6 L of fluid in the ED were 90% more likely to develop symptoms of CHF exacerbation with no evidence of lowering mortality compared to the group that received less than 2.6 L. Our data supports the practice of limiting total fluid resuscitation in CHF to 2.6 L and reconfirms the idea that fluid resuscitation for patients with CHF needs to be individualized.
- Open Access
THE EFFECT OF DIOXIN ON LOW BIRTH WEIGHT IN SOUTHERN WEST VIRGINIA BETWEEN 1955 – 1969
Objective: The effect of low birth weight as a result of dioxin-based exposure has been investigated through the existing literature, but the debate on exact point source and production is still debated. The Monsanto factory located in Nitro, West Virginia produced Agent Orange from 1948 – 1969. Methods: The vital statistics registry from the state of West Virginia of Kanawha county and Putnam county West Virginia. The production of dioxin and 2-4-5T was obtained from the legal files from (Civil Action No. 04-C-465) and the expert witness of Dr. Bruce Bell. In order to understand this relationship a time series analysis was conducted to compare 2-4-5T and dioxin and low-birthweight in Kanawha County and Putnam County, West Virginia. Results: The results suggest dioxin within Kanawha county had a suggestive relationship associated with dioxin production and low birthweight from 1948-1969 had a suggestive relationship of ( p = 0.042). The comparison county of Putnam had no statistically significant relationship between low birthweight and dioxin production ( p = 0.203). Agent Orange (2-4-5t) was also considered and measured within the counties of Kanawha and Putnam Counties, within these two counties no statistically significant relationship was observed. Conclusions: In conclusion the association between dioxin and low birthweight still requires more research but this analysis illustrates that there appears to be a suggestive relationship that exists within Kanawha County, West Virginia as related to the production of and effect of the by-product of dioxin.
Open AccessTHE EFFECT OF DIOXIN ON LOW BIRTH WEIGHT IN SOUTHERN WEST VIRGINIA BETWEEN 1955 – 1969
Objective: The effect of low birth weight as a result of dioxin-based exposure has been investigated through the existing literature, but the debate on exact point source and production is still debated. The Monsanto factory located in Nitro, West Virginia produced Agent Orange from 1948 – 1969. Methods: The vital statistics registry from the state of West Virginia of Kanawha county and Putnam county West Virginia. The production of dioxin and 2-4-5T was obtained from the legal files from (Civil Action No. 04-C-465) and the expert witness of Dr. Bruce Bell. In order to understand this relationship a time series analysis was conducted to compare 2-4-5T and dioxin and low-birthweight in Kanawha County and Putnam County, West Virginia. Results: The results suggest dioxin within Kanawha county had a suggestive relationship associated with dioxin production and low birthweight from 1948-1969 had a suggestive relationship of ( p = 0.042). The comparison county of Putnam had no statistically significant relationship between low birthweight and dioxin production ( p = 0.203). Agent Orange (2-4-5t) was also considered and measured within the counties of Kanawha and Putnam Counties, within these two counties no statistically significant relationship was observed. Conclusions: In conclusion the association between dioxin and low birthweight still requires more research but this analysis illustrates that there appears to be a suggestive relationship that exists within Kanawha County, West Virginia as related to the production of and effect of the by-product of dioxin.
- Open Access
- 30 October 2019
- Published by Springer Nature in Cureus
- Vol. 11 (10) , e6030
Our Experience with Transcatheter Aortic Valve Replacement Medication Outcomes from 2013 to 2016
Aortic stenosis is classified as stenosis that can be caused by a congenital disability in infants and children but is more commonly produced by a degenerative process of calcification and scarring of the valve in the later decades of life. High systemic pressure and hemodynamic disturbances characteristic of this area of the cardiovascular system makes the aortic valve susceptible to plaque and cholesterol buildup over time, similarly to atherosclerosis, contributing to the pathology of aortic stenosis. Thus, this study aims to assess the short and long-term clinical outcomes of risk factor reduction, post transcatheter aortic valve replacement (post-TAVR), and results of tested medication outcomes. Data were obtained from Charleston Area Medical Center, which is a tertiary care 800-bed community teaching facility and was examined using STATA 11.4 (StataCorp LLC, College Station, Texas, USA), a Cox proportional hazards model to test for clinical significance. This study examined the medications aspirin, clopidogrel, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors. Additional medications analyzed included statin, anticoagulant, aspirin with clopidogrel, and beta-blocker with ACE inhibitor and statin following the procedure of transcatheter aortic valve replacement (TAVR) and the overall risk of a hazard event of mortality. Results suggest that clopidogrel by itself had the lower rate of mortality at one year with hazards of 0.6906, a p-value of 0.221 and a 95% confidence interval of 0.3677 - 1.259; and at three years with hazards of 0.4845, a p-value of 0.027 and a 95% confidence interval of 0.2552 - 0.9201. Statins had the second-lowest rate at one year with hazards of 0.7299 and a p-value 0.215 and a 95% confidence interval of 0.4438 - 1.200; and at three years with hazard of 0.8529 and a p-value of 0.530 and a 95% confidence interval of 0.5192 - 1.401. Both of these medications had a consistent lower hazard and/or risk of death compared to other standard medication regiments. Within our center's data, clopidogrel had the best clinical outcome. This study showed that therapy with aspirin and clopidogrel alone did not demonstrate a significant increase in mortality versus alternative anticoagulation therapy in patients post aortic valve replacement. Clopidogrel and statin usage post-aortic valve revascularization may have a trend towards a reduction in mortality.
- 30 October 2019
- Published by Springer Nature in Cureus
- Vol. 11 (10) , e6030
Open AccessOur Experience with Transcatheter Aortic Valve Replacement Medication Outcomes from 2013 to 2016
Aortic stenosis is classified as stenosis that can be caused by a congenital disability in infants and children but is more commonly produced by a degenerative process of calcification and scarring of the valve in the later decades of life. High systemic pressure and hemodynamic disturbances characteristic of this area of the cardiovascular system makes the aortic valve susceptible to plaque and cholesterol buildup over time, similarly to atherosclerosis, contributing to the pathology of aortic stenosis. Thus, this study aims to assess the short and long-term clinical outcomes of risk factor reduction, post transcatheter aortic valve replacement (post-TAVR), and results of tested medication outcomes. Data were obtained from Charleston Area Medical Center, which is a tertiary care 800-bed community teaching facility and was examined using STATA 11.4 (StataCorp LLC, College Station, Texas, USA), a Cox proportional hazards model to test for clinical significance. This study examined the medications aspirin, clopidogrel, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors. Additional medications analyzed included statin, anticoagulant, aspirin with clopidogrel, and beta-blocker with ACE inhibitor and statin following the procedure of transcatheter aortic valve replacement (TAVR) and the overall risk of a hazard event of mortality. Results suggest that clopidogrel by itself had the lower rate of mortality at one year with hazards of 0.6906, a p-value of 0.221 and a 95% confidence interval of 0.3677 - 1.259; and at three years with hazards of 0.4845, a p-value of 0.027 and a 95% confidence interval of 0.2552 - 0.9201. Statins had the second-lowest rate at one year with hazards of 0.7299 and a p-value 0.215 and a 95% confidence interval of 0.4438 - 1.200; and at three years with hazard of 0.8529 and a p-value of 0.530 and a 95% confidence interval of 0.5192 - 1.401. Both of these medications had a consistent lower hazard and/or risk of death compared to other standard medication regiments. Within our center's data, clopidogrel had the best clinical outcome. This study showed that therapy with aspirin and clopidogrel alone did not demonstrate a significant increase in mortality versus alternative anticoagulation therapy in patients post aortic valve replacement. Clopidogrel and statin usage post-aortic valve revascularization may have a trend towards a reduction in mortality.
- 2 March 2019
- Published by Wiley in AEM Education and Training
- Vol. 3 (3) , 280-285
Comparison of Manikin Versus Porcine Trachea Models When Teaching Emergent Cricothyroidotomy Among Emergency Medicine Residents
Objectives: Emergent cricothyroidotomy (EC) is a rarely used yet lifesaving procedure that is important for an emergency physician to master throughout his or her training. We evaluated the difference in utilization of a manikin or porcine model among emergency medicine (EM) residents when teaching EC. We also evaluated the difference in the models using two different commonly utilized and taught techniques: “scalpel‐finger‐bougie” (SFB) technique and the Melker technique (MT).Methods: This was a prospective crossover design. Instructions about the procedure were provided; study participants were randomly assigned to one of two groups and performed cricothyrotomy on both manikin and porcine simulators using both the Melker and the SFB techniques. Each group was started with the technique on the second simulator opposite what they started with on the first simulator. After the procedures, study participants completed a questionnaire that used the same format for both groups. All survey questions required a 7‐point Likert scale response. Confidence, difficulty, reality of the anatomy, and landmarks were compared.Results: Fifteen EM residents participated in the study. Compared to the porcine‐first group, the manikin‐first group rated the anatomy more realistic (question 5) after their first attempt (6.29 vs. 5.87) than their second attempt (using the porcine model; 4.29 vs. 5.62; main effect for attempts [first vs. second] p = 0.027; interaction p = 0.074). Interestingly, the porcine model–first group rated the landmarks (question 6) significantly easier to find in both attempts (6.87 vs. 5.86 on the first attempt and 6.50 vs. 5.57 on the second attempt; p = 0.012). Twelve participants (80%) chose SFB as their preferred technique to use in real‐life scenario.Conclusion: The Manikin model tends to be more realistic in cricothyrotomy simulation than the porcine model. The influence of fresh pig skin overlying the porcine model may require further research. Landmark identification during the procedure was easier on both models when participants start with the porcine model. Participants prefer the SFB over MT if faced with a real‐life scenario.
- 2 March 2019
- Published by Wiley in AEM Education and Training
- Vol. 3 (3) , 280-285
Comparison of Manikin Versus Porcine Trachea Models When Teaching Emergent Cricothyroidotomy Among Emergency Medicine Residents
Objectives: Emergent cricothyroidotomy (EC) is a rarely used yet lifesaving procedure that is important for an emergency physician to master throughout his or her training. We evaluated the difference in utilization of a manikin or porcine model among emergency medicine (EM) residents when teaching EC. We also evaluated the difference in the models using two different commonly utilized and taught techniques: “scalpel‐finger‐bougie” (SFB) technique and the Melker technique (MT).Methods: This was a prospective crossover design. Instructions about the procedure were provided; study participants were randomly assigned to one of two groups and performed cricothyrotomy on both manikin and porcine simulators using both the Melker and the SFB techniques. Each group was started with the technique on the second simulator opposite what they started with on the first simulator. After the procedures, study participants completed a questionnaire that used the same format for both groups. All survey questions required a 7‐point Likert scale response. Confidence, difficulty, reality of the anatomy, and landmarks were compared.Results: Fifteen EM residents participated in the study. Compared to the porcine‐first group, the manikin‐first group rated the anatomy more realistic (question 5) after their first attempt (6.29 vs. 5.87) than their second attempt (using the porcine model; 4.29 vs. 5.62; main effect for attempts [first vs. second] p = 0.027; interaction p = 0.074). Interestingly, the porcine model–first group rated the landmarks (question 6) significantly easier to find in both attempts (6.87 vs. 5.86 on the first attempt and 6.50 vs. 5.57 on the second attempt; p = 0.012). Twelve participants (80%) chose SFB as their preferred technique to use in real‐life scenario.Conclusion: The Manikin model tends to be more realistic in cricothyrotomy simulation than the porcine model. The influence of fresh pig skin overlying the porcine model may require further research. Landmark identification during the procedure was easier on both models when participants start with the porcine model. Participants prefer the SFB over MT if faced with a real‐life scenario.
- 1 February 2019
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 37 (2) , 370-371
The social media diagnosis of Superior Vena Cava Syndrome: A case report
- 1 February 2019
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 37 (2) , 370-371
The social media diagnosis of Superior Vena Cava Syndrome: A case report
- 25 January 2019
- Published by Elsevier in Visual Journal of Emergency Medicine
- Vol. 15, 100570
Elderly man with painful vision loss
- 25 January 2019
- Published by Elsevier in Visual Journal of Emergency Medicine
- Vol. 15, 100570
Elderly man with painful vision loss
- Open Access
- 4 December 2018
- Published by Springer Nature in Cureus
- Vol. 10 (12) , e3682
Clinical Features and Outcomes of Peripheral Vascular Disease Patients Receiving Red Blood Cell Transfusions
Peripheral vascular disease (PVD) patients are commonly transfused with red blood cells (RBC) due to their inability to compensate for anemia and blood loss. Anemias, as well as allogeneic transfusions, have been demonstrated as independent risk factors for increased mortality and morbidity following cardiovascular procedures. The relationships between anemia, transfusion, and adverse outcomes in PVD patients remain unascertained and understudied. A retrospective cohort study was conducted to determine mortality at 30-day, one-year, and three-year markers among 330 randomly selected PVD patients. The clinical features of patients receiving transfusions were examined, and the mortality rates were compared between patients who received an RBC transfusion and those who did not. Cox regression analysis was employed to identify independent variables predicting mortality. Transfusions were found to have increased mortality rates over non-transfused patients at 30 days (6.1% vs. 1.8%, p = 0.05), one year (21.8% vs 12.1%, p = 0.02), and three years (41.2% vs. 23.0%, p = 0.001). Using a multivariate regression model, it was determined that the transfusion itself was not a significant cause of this decrease in survival, while the propensity to transfuse was a predictor for both short (30 days, 36.73 [1.85-728.06], p = 0.04) and long-term mortality (one year (8.83 [2.62-29.77], p < 0.001; three years (7.07 [1.46-8.07], p <0.01). Anti-coagulation therapy using intravenous (IV) heparin and the chronic comorbidities of coronary artery disease and diabetes mellitus were also robust independent predictors of decreased survival. This study was able to find an association between RBC transfusion and reduction in short-term (three months) and long-term (three years) survival. Those requiring IV heparin during the hospital stay were at an increased risk of requiring blood transfusion, and patients receiving IV heparin were also found to have a significant increase in mortality rates.
- 4 December 2018
- Published by Springer Nature in Cureus
- Vol. 10 (12) , e3682
Open AccessClinical Features and Outcomes of Peripheral Vascular Disease Patients Receiving Red Blood Cell Transfusions
Peripheral vascular disease (PVD) patients are commonly transfused with red blood cells (RBC) due to their inability to compensate for anemia and blood loss. Anemias, as well as allogeneic transfusions, have been demonstrated as independent risk factors for increased mortality and morbidity following cardiovascular procedures. The relationships between anemia, transfusion, and adverse outcomes in PVD patients remain unascertained and understudied. A retrospective cohort study was conducted to determine mortality at 30-day, one-year, and three-year markers among 330 randomly selected PVD patients. The clinical features of patients receiving transfusions were examined, and the mortality rates were compared between patients who received an RBC transfusion and those who did not. Cox regression analysis was employed to identify independent variables predicting mortality. Transfusions were found to have increased mortality rates over non-transfused patients at 30 days (6.1% vs. 1.8%, p = 0.05), one year (21.8% vs 12.1%, p = 0.02), and three years (41.2% vs. 23.0%, p = 0.001). Using a multivariate regression model, it was determined that the transfusion itself was not a significant cause of this decrease in survival, while the propensity to transfuse was a predictor for both short (30 days, 36.73 [1.85-728.06], p = 0.04) and long-term mortality (one year (8.83 [2.62-29.77], p < 0.001; three years (7.07 [1.46-8.07], p <0.01). Anti-coagulation therapy using intravenous (IV) heparin and the chronic comorbidities of coronary artery disease and diabetes mellitus were also robust independent predictors of decreased survival. This study was able to find an association between RBC transfusion and reduction in short-term (three months) and long-term (three years) survival. Those requiring IV heparin during the hospital stay were at an increased risk of requiring blood transfusion, and patients receiving IV heparin were also found to have a significant increase in mortality rates.
- Open Access
- 3 December 2018
- Published by Springer Nature in Cureus
- Vol. 10 (12) , e3673
Alternative Treatment Approach for Right Heart Masses
The traditional therapeutic approach for heart masses has been surgical resection. For right-sided masses, percutaneous mechanical thrombectomy (PMT) is a viable treatment option which is being applied with increasing frequency. This newer treatment modality is less invasive, less expensive, and results in shorter hospital stays compared to cardiac surgery. We demonstrate below a case in which rheolytic PMT was utilized successfully, allowing the patient to be discharged the following day.
- 3 December 2018
- Published by Springer Nature in Cureus
- Vol. 10 (12) , e3673
Open AccessAlternative Treatment Approach for Right Heart Masses
The traditional therapeutic approach for heart masses has been surgical resection. For right-sided masses, percutaneous mechanical thrombectomy (PMT) is a viable treatment option which is being applied with increasing frequency. This newer treatment modality is less invasive, less expensive, and results in shorter hospital stays compared to cardiac surgery. We demonstrate below a case in which rheolytic PMT was utilized successfully, allowing the patient to be discharged the following day.